Literature DB >> 26380190

Pros: long-term CT scan follow-up should be the standard of care in patients who are curatively treated for an early-stage non-small cell lung cancer.

Waël C Hanna1.   

Abstract

Entities:  

Year:  2015        PMID: 26380190      PMCID: PMC4549466          DOI: 10.3978/j.issn.2218-6751.2015.07.09

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


× No keyword cloud information.
  13 in total

1.  Follow-up of non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.

Authors:  W T Sause; R W Byhardt; W J Curran; D Fuller; M V Graham; B Ko; R Komaki; T H Weisenburger; L R Kaiser; S A Leibel; R C Brown
Journal:  Radiology       Date:  2000-06       Impact factor: 11.105

Review 2.  American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

Authors:  David G Pfister; David H Johnson; Christopher G Azzoli; William Sause; Thomas J Smith; Sherman Baker; Jemi Olak; Diane Stover; John R Strawn; Andrew T Turrisi; Mark R Somerfield
Journal:  J Clin Oncol       Date:  2003-12-22       Impact factor: 44.544

3.  The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.

Authors:  Michael T Jaklitsch; Francine L Jacobson; John H M Austin; John K Field; James R Jett; Shaf Keshavjee; Heber MacMahon; James L Mulshine; Reginald F Munden; Ravi Salgia; Gary M Strauss; Scott J Swanson; William D Travis; David J Sugarbaker
Journal:  J Thorac Cardiovasc Surg       Date:  2012-07       Impact factor: 5.209

Review 4.  How to follow up patients after curative resection of lung cancer.

Authors:  Waël C Hanna; Shaf Keshavjee
Journal:  Semin Thorac Cardiovasc Surg       Date:  2013

5.  Minimal-dose computed tomography is superior to chest x-ray for the follow-up and treatment of patients with resected lung cancer.

Authors:  Waël C Hanna; Narinder S Paul; Gail E Darling; Hadas Moshonov; Frances Allison; Thomas K Waddell; Marcelo Cypel; Marc E de Perrot; Kazuhiro Yasufuku; Shaf Keshavjee; Andrew F Pierre
Journal:  J Thorac Cardiovasc Surg       Date:  2013-10-18       Impact factor: 5.209

6.  Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer.

Authors:  Robert J Korst; Amanda L Kansler; Jeffrey L Port; Paul C Lee; Nasser K Altorki
Journal:  Ann Thorac Surg       Date:  2006-09       Impact factor: 4.330

7.  Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition).

Authors:  Jeffrey Rubins; Michael Unger; Gene L Colice
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

Review 8.  Postoperative surveillance for non-small cell lung cancer resected with curative intent: developing a patient-centered approach.

Authors:  Nathan M Mollberg; Mark K Ferguson
Journal:  Ann Thorac Surg       Date:  2013-01-23       Impact factor: 4.330

9.  Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma.

Authors:  R Taylor Ripley; Robert R McMillan; Camelia S Sima; Saad M Hasan; Usman Ahmad; Feiran Lou; David R Jones; Valerie W Rusch; Nabil P Rizk; James Huang
Journal:  Ann Thorac Surg       Date:  2014-07-16       Impact factor: 4.330

Review 10.  Survival benefits from follow-up of patients with lung cancer: a systematic review and meta-analysis.

Authors:  Lynn Calman; Kinta Beaver; Daniel Hind; Paul Lorigan; Chris Roberts; Myfanwy Lloyd-Jones
Journal:  J Thorac Oncol       Date:  2011-12       Impact factor: 15.609

View more
  2 in total

1.  Rebuttal from Dr van Meerbeeck.

Authors:  Jan P van Meerbeeck
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Long-Term Prognosis and Prognostic Indicators of Stage IA Lung Adenocarcinoma.

Authors:  Masaya Yotsukura; Yuji Muraoka; Yukihiro Yoshida; Kazuo Nakagawa; Kouya Shiraishi; Takashi Kohno; Yasushi Yatabe; Shun-Ichi Watanabe
Journal:  Ann Surg Oncol       Date:  2022-10-19       Impact factor: 4.339

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.